The manufacturer was informed of the following event through mantra study database.Reportedly, a perceval plus valve size xl was implanted in the patient on (b)(6) 2023.Based on the information available, patient had junctional / conversion pauses following atrial fibrillation that started on (b)(6) 2023.As such, a permanent pacemaker was implanted on the same day to resolve the event.The event severity was considered moderate.As reported, the patient's clinical history included systemic hypertension; dyslipidemia; laa thrombus; peptic ulcer disease; and nyha class ii.
|